Real-Time PCR (qPCR) Market to reach USD 10.30 billion by 2032 and grow at a CAGR of 4.67%.
The real-time PCR (qPCR) market is promising with the growing incidence of genetic disorders, infectious diseases, as well as chronic diseases. According to the CDC, congenital heart defects occur in approximately 1 percent of U.S. births yearly, thus a big demand for early detection and intervention through advanced diagnostics like qPCR. The critical need for PCR techniques applied to detect genetic variations for prenatal testing as well as diagnosis and prevention of diseases such as HIV, HPV, Alzheimer\'s, and Parkinson\'s disease is expanding the market. For instance, many European countries experienced an increase in invasive group A streptococcal (GAS) infections in children during the season of 2022-2023, leading to an increased demand for PCR-based diagnostics.